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Chromium toxicity <p>Competitive growth between over 6,000 heterozygous yeast mutants in the presence of chromium together with microarray-based  screens showed that proteasomal activity is crucial for cellular chromium resistance.</p>
Abstract
Background: The serious biological consequences of metal toxicity are well documented, but the
key modes of action of most metals are unknown. To help unravel molecular mechanisms
underlying the action of chromium, a metal of major toxicological importance, we grew over 6,000
heterozygous yeast mutants in competition in the presence of chromium. Microarray-based
screens of these heterozygotes are truly genome-wide as they include both essential and non-
essential genes.
Results: The screening data indicated that proteasomal (protein degradation) activity is crucial for
cellular chromium (Cr) resistance. Further investigations showed that Cr causes the accumulation
of insoluble and toxic protein aggregates, which predominantly arise from proteins synthesised
during Cr exposure. A protein-synthesis defect provoked by Cr was identified as mRNA
mistranslation, which was oxygen-dependent. Moreover, Cr exhibited synergistic toxicity with a
ribosome-targeting drug (paromomycin) that is known to act via mistranslation, while manipulation
of translational accuracy modulated Cr toxicity.
Conclusion: The datasets from the heterozygote screen represent an important public resource
that may be exploited to discover the toxic mechanisms of chromium. That potential was validated
here with the demonstration that mRNA mistranslation is a primary cause of cellular Cr toxicity.
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Background
Toxic metals are major environmental pollutants that are
linked to a broad range of degenerative conditions in humans
[1-3]. Metal toxicity is also widely studied in microorganisms,
both as models to further our understanding of cellular metal
toxicology, and because of the importance of metal toxicity in
microbial biotechnologies [4-7]. Chromium toxicity is an
issue of especially broad interest, Cr compounds having been
among the earliest chemicals to be classified as carcinogens.
Although the consequences of chromium toxicity are well
documented [8], the underlying cause(s) of toxicity remains
unknown. This is a key issue, as an understanding of mecha-
nism should help develop appropriate therapies.
The yeast Saccharomyces cerevisiae is at the forefront of
functional genomics and systems biology research [9] and
provides an excellent model with which to tackle intractable
biological questions. The yeast deletion strain collections
have proven particularly valuable resources, the homozygous
versions having been used widely for genome-wide assign-
ment of function [10-13]. The heterozygous deletion strain
collection [14] has been less commonly exploited. This
reflects (in part) the more subtle phenotypes that the reduc-
tion in the copy number of a given gene (from two copies to
one), as opposed to its complete removal, is expected to pro-
duce. This subtlety means that small differences in growth
rate of individual heterozygous mutants must be detected,
and this is most easily achieved by competition experiments.
These experiments are generally carried out by pooling the
entire collection of mutants and growing them in competition
under the condition of interest [11,15]. Analysis of the compe-
titions is facilitated by the fact that the gene replacement cas-
sette for each mutant has a unique 20-mer strain-identifying
sequence [10,14]. These molecular 'barcodes' are amplifiable
with common primers, enabling a parallel analysis of all
strains in the mixed culture and avoiding the need to culture
each strain separately to assess growth effects. Total genomic
DNA extracted from the mixed competitions is subjected to
PCR with the universal primers, yielding a pool of amplified
tag sequences in which the abundance of each unique tag cor-
responds to the abundance of a strain in the culture [14,16].
These abundances can be determined quantitatively by
hybridization to oligonucleotide arrays, the data revealing the
relative growth of each yeast mutant under the growth condi-
tion(s) of interest.
A major advantage of the heterozygous deletion strain collec-
tion is that it encompasses essential gene functions that, by
definition, are not represented in the homozygous collections.
Therefore, exploitation of the heterozygous mutant collection
through competition analyses should provide a considerably
richer pool of information. Essential gene products are likely
cellular targets of drugs and other xenobiotics. Consequently,
existing data from screens of the homozygous mutant collec-
tions against agents such as mutagens and toxic metals [17-
19], although very useful, exclude potentially key informa-
tion. Furthermore, mutation to heterozygosity is common in
nature, and such heterozygosities can underlie human genetic
diseases [20].
The proof-of-principle of competition analyses employing the
heterozygous yeast deletion mutants involved confirmation
or identification of essential proteins as targets of drug action
[14,15,21]. For those purposes, large collections of pooled
mutants were co-incubated with the drug and the relative
growth effect of the drug on each strain assayed as outlined
above. Genes were identified that yielded haploinsufficiency
phenotypes. Haploinsufficiency describes the situation where
halving the copy number of a gene (to create a heterozygous
mutant) provides insufficient gene product for optimal
growth under a particular condition. Therefore, the above
studies identified (essential) genes that are required for opti-
mal growth in the presence of the drugs, revealing putative
drug targets. Another phenomenon, not yet exploited in the
above context, is haploproficiency (that is, a fitness benefit
arising from heterozygosity). Recent work has highlighted the
value of considering haploproficiency. For instance, genes
with functions related to protein turnover showed haplopro-
ficiency under conditions of nitrogen limitation, where pro-
tein conservation might be expected to yield a selective
advantage [22].
Armed with these convincing proofs of principle, the present
study extends the use of competition analyses, beyond the
identification of drug targets, to a natural stressor that is not
necessarily expected to have a primary protein target - the
toxic metal chromium. Prior to our study intense efforts to
characterize the toxic action of chromium have been made,
but the primary molecular mechanisms causing toxicity have,
nevertheless, remained elusive. Here we show that mRNA
mistranslation is a primary cause of cellular Cr toxicity.
Results
Identification of heterozygotes with altered chromium 
resistances
The experimental system involved co-culture of >6,000 het-
erozygous (hemizygous) deletion strains in carbon-limited
continuous culture. A number of similar studies have co-cul-
tured the heterozygotes in batch culture [15,21], whereas a
more recent study with the heterozygotes has used the same
continuous culture system as that employed here [22]. The
use of continuous culture for competitions enables detection
of the more subtle phenotypes, expressed as small growth
rate differences and revealed over a large number of genera-
tions. In addition, use of the chemostat for continuous culture
offers high reproducibility, owing to a defined and constant
growth rate and physicochemical environment at steady
state. CrO3 was supplied at a sub-lethal dose (0.1 mM), pre-
determined to cause an approximately 30% increase in the
mean doubling time of the mixed cultures. The relative
growth of each strain in the cultures (that is, change in rela-http://genomebiology.com/2007/8/12/R268 Genome Biology 2007,     Volume 8, Issue 12, Article R268       Holland et al. R268.3
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tive abundance between the start and end of a chemostat
experiment) was derived from signals assigned to the strains'
unique identifying (barcode) sequences (see Background, and
Materials and methods). The effect of Cr was determined by
comparing the relative growth of each strain in the Cr-treated
cultures versus that in control cultures. This yielded a value
for each strain for the size of the growth effect of Cr (see the
Data analysis section in Materials and methods). The data for
each strain are given in Additional data file 1.
The range of growth effects of Cr across the strains indicated
a normal distribution centered around zero (Figure 1). The
relative growth of some strains was decreased by Cr (negative
growth effect; tendency towards haploinsufficiency with Cr),
whereas others showed improved relative growth (tendency
towards haploproficiency). A similar normal distribution was
evident for growth effects on strains that were heterozygous
specifically for essential gene functions. The growth data were
analyzed further to identify strains that showed significant
(false discovery rate, q < 0.05) haploinsufficiency or haplo-
proficiency (see the Data analysis section in Materials and
methods). There were fewer significantly haploinsufficient
strains than haploproficient ones, that is, 115 strains exhib-
ited a Cr-specific growth defect (indicating gene functions
that normally protect against Cr), whereas the relative com-
petitiveness of 203 strains was enhanced by Cr (indicating
functions through which metal toxicity could be mediated).
This suggests that S. cerevisiae has not been routinely
exposed to Cr stress during its evolutionary history, as Fisher
[23] demonstrated that when selection occurs in the environ-
ment to which an organism is adapted, then most mutations
will be deleterious; whereas, when selection occurs in increas-
ingly suboptimal conditions, then an increasing proportion of
mutations will be beneficial. Knowledge of genes that exhibit
haploproficient phenotypes in the presence of Cr could be
exploited to increase the rate of biotechnological processes
that may be limited by metal toxicity [4,7].
In contrast to the therapeutic compounds that were the sub-
jects of previous haploinsufficiency analyses [14,15,21,24],
there is no a priori expectation that the primary target of Cr
will be a specific essential protein [5]. Nonetheless, closer
analysis of our data showed that, under the condition of Cr
stress, five of the eight most significant haploinsufficient phe-
notypes (that is, those with the lowest q-values) were found in
strains heterozygous for an essential gene (Additional data
file 1). These included NHP2 (involved in 18S rRNA process-
ing), and ARP3 and ARC19 (involved in actin nucleation and
actin patch function). As with the drugs, these observations
could, in principle, be explained by direct interference of the
metal with the essential function of its target protein, reduc-
ing its activity to a level below that required to sustain the
growth of a diploid cell at wild-type rates. Alternatively (and
this also applies to the haploinsufficient phenotypes observed
for non-essential genes), there may be a synthetic lethal inter-
action with the principal target of chromium, or the haploin-
sufficient protein may contribute to the intrinsic resistance of
the cell to the toxic action of the metal.
Over-representation of specific Gene Ontology terms 
in the annotations of genes found in the 
haploinsufficiency and haploproficiency datasets
GoMiner [25] was used to associate Gene Ontology (GO)
terms with all genes whose heterozygous mutants exhibited
significant haploinsufficiency or haploproficiency under Cr
stress (Additional data file 2). Not unexpectedly, GO terms
related to transport and metal homeostasis were significantly
over-represented in the annotation of those genes that dis-
played either haploinsufficient or haploproficient pheno-
types. Gene functions involved with chromatin structure were
also significantly over-represented in the haploinsufficient
and haploproficient data, indicating an involvement of chro-
matin organization and its possible effects on gene expression
in Cr resistance. Schnekenburger et al. [26] have described
how Cr cross-links complexes of histone deacetylase 1 and
DNA methyltransferase 1 to gene promoters, inhibiting his-
tone modifications and decreasing recruitment of RNA
polymerase. Cr may also provoke aberrant DNA methylation,
with the potential to silence tumor suppressor genes in higher
cells [27]. Genes involved in nucleotide excision repair also
were evidently important for Cr resistance, consistent with
Analysis of the global effects of Cr treatment on the heterozygous mutants Figure 1
Analysis of the global effects of Cr treatment on the heterozygous 
mutants. The plot shows the distribution of the sizes of the growth effects 
caused by Cr for all genes (black line) and essential genes (grey line). 
Mutants were grouped into bins according to the size of growth effect. 
Each bin encompasses a 0.0025 range of growth-effect sizes, and the 
frequency denotes the number of strains in each bin. The calculation for 
determining size of growth effect is described in the Data analysis section 
in Materials and methods.
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previous work [28]. Cr is well known to promote DNA dam-
age, but it is unresolved whether this is a primary cause (ver-
sus a secondary effect) of Cr toxicity.
The Cr treatment revealed haploproficient phenotypes for
several genes involved in sulfur metabolism. The flux of sulfur
in these heterozygotes could be re-directed towards
molecules that may promote metal resistance, such as glu-
tathione (GSH). Such re-programming of sulfur metabolism
occurs normally in wild-type yeast responding to other metals
[29,30]. In addition, Cr uptake may occur through sulfate
transporters, which are regulated in response to Cr stress
[31]. Actin was a highly over-represented haploinsufficient
category for Cr, which might relate to targeting of actin func-
tion by Cr, as suggested above.
Proteins synthesized during chromium exposure tend 
to form aggregated toxic-products
Genes involved in proteasome function and regulation of pro-
tein stability were among those most significantly over-repre-
sented in the set showing haploinsufficient phenotypes in the
presence of Cr (Additional data file 2). We decided to subject
this evidence of the mechanism of chromium's toxicity to fur-
ther investigation. Initially, we validated the output from the
library screen by confirming in independent batch-culture
assays the haploinsufficient phenotypes of several Cr-treated
proteasome mutants (Additional data file 3). These data point
to a requirement for protein degradation in Cr resistance and,
therefore, to an involvement of cellular proteins in Cr toxicity.
This hypothesis was supported by experiments involving
cycloheximide, an inhibitor of translational elongation. Expo-
sure of cells to Cr for 3 h resulted in a marked loss of viability
(Figure 2a). However, this toxicity was suppressed in cells
that were blocked for protein synthesis using cycloheximide.
Previous evidence showed that Cr toxicity involves protein
oxidation [32]. Oxidized proteins are prone to forming poten-
tially toxic aggregates [33], but this can be countered by pro-
teasomal degradation of the abberant proteins. Combining
those observations with our new haploinsufficiency data, we
hypothesized that Cr toxicity could involve the formation of
protein aggregates. Protein aggregation is also linked to can-
cer [33], and the carcinogenicity of Cr is well-documented [8].
To test the effect of Cr on protein aggregation, insoluble
aggregate fractions of proteins were isolated from cells (see
Materials and methods) that had been incubated with or
without Cr, and the levels of protein in these fractions were
determined. The proportion of cellular protein occurring as
insoluble aggregates was found to increase approximately
two-fold during Cr exposure (Figure 2b), indicating that Cr
Chromium causes accumulation of toxic protein aggregates Figure 2
Chromium causes accumulation of toxic protein aggregates. (a) Exponential phase cells of S. cerevisiae in YEPD medium were exposed to 9 or 12 mM 
CrO3 for 3 h, in either the absence or presence of 10 μg ml-1 cycloheximide (CHX) (the latter cells were also pre-incubated for 1 h with CHX before 
metal exposure). Viability (%) was subsequently determined according to colony-forming-unit counts, with reference to control cultures not exposed to 
Cr. (b) Protein was extracted from cells treated for 30 minutes with 0.5 mM CrO3 and an aggregated protein fraction (separated from soluble and 
membrane proteins) [49] was prepared from each sample. The data show protein determined in the aggregate fraction as a proportion of the total cellular 
protein. (c) Cells were cultured in YEPD medium that was either unsupplemented with protein (open circles), or supplemented with 24 μg ml-1 of the 
soluble (filled circles) or aggregated (squares) protein fractions isolated from cells that had been exposed to 0.2 mM CrO3 for 1 h. All values are means ± 
standard error of the mean from at least three independent determinations.
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promotes protein aggregation. Protein aggregates can be
toxic, and the potential toxicities of aggregate preparations
from cells can be tested by exposing fresh cells to these and
measuring their inhibitory effect [34] on the growth of S. cer-
evisiae. Growth was not affected by supplementing the
medium with soluble protein that was previously isolated
f r o m  C r - t r e a t e d  c e l l s  ( F i g u r e  2 c ) .  I n  c o n t r a s t ,  g r o w t h  w a s
slowed in medium supplemented with an equivalent amount
of aggregated protein from the Cr-treated cells. Therefore,
aggregated protein formed in the presence of Cr can exert a
toxic effect.
The observation that Cr resistance was enhanced by the
simultaneous inhibition of protein synthesis (Figure 2a) sug-
gested that proteins synthesized during Cr exposure were
involved in toxicity. To explore this further, the source of Cr-
induced protein aggregates was determined with pulse-chase
experiments involving protein labeling with [35S]methionine.
These experiments showed that Cr-dependent aggregation
was attributable primarily to proteins synthesized during Cr
exposure, rather than to aggregation of pre-existing proteins:
the aggregate fraction isolated from cells that were
[35S]methionine-labeled during the period of Cr exposure was
enriched with labeled protein (Figure 3a), whereas the oppo-
site was true for cells labeled prior to Cr exposure (Figure 3b).
(In the latter case, there was a decrease in the proportion of
labeled protein in the aggregate fraction following incubation
with Cr. This could be due to dilution of pre-existing labeled
aggregates with unlabelled aggregates formed during the
incubation with Cr.) In other experiments, co-treatment with
cycloheximide suppressed the Cr-dependent accumulation of
protein aggregates (Figure 3c), supporting the conclusion
that proteins that form insoluble aggregates in response to Cr
are predominantly synthesized during Cr exposure.
Mistranslation of mRNA is a primary cause of 
chromium toxicity
The finding that Cr causes aggregation primarily among pro-
teins being synthesized during exposure suggested that the
metal might be targeting the protein synthesis or folding
machineries. Mistranslation of mRNA transcripts provides a
major potential source of aberrant proteins that form aggre-
gates [33]. To test whether Cr provokes mRNA mistransla-
tion, the rate of translational read-through of a UAA nonsense
(stop) codon was monitored in a short-term dual-luciferase
assay (see Materials and methods). The rate of read-through
was increased more than two-fold by the addition of CrO3, at
a concentration that increased the population doubling time
by about 15% (Figure 4a). A similarly inhibitory dose of
another metal, Cu(NO3)2, did not significantly affect read-
Chromium causes aggregation predominantly of proteins synthesized during chromium exposure Figure 3
Chromium causes aggregation predominantly of proteins synthesized during chromium exposure. Cells were exposed to 0.1 mM CrO3 for 60 minutes, 
either (a) at the same time as or (b) after labeling with [35S]methionine for 60 minutes. The data show the relative enrichment of isotope in the aggregate 
fraction [cpm per μg aggregated protein, corrected for labeling efficiency (cpm per μg total protein)]. (b) Due to the natural turnover of labeled proteins 
during the post-labeling 60 minute incubation ± Cr, the data from this experiment were normalized with respect to the minus-Cr control from (a). (c) 
Aggregated protein as a proportion of total protein was determined after incubation of cells for 1 h in the absence or presence of 0.4 mM CrO3 and 10 μg 
ml-1 cycloheximide (CHX). All values are means ± standard error of the mean from three independent determinations.
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through across the stop codon. The ribosome-targeting drug
paromomycin caused a stimulation of mistranslation compa-
rable to that observed with Cr. These data were supported by
results from a longer-term qualitative assay, based on read-
through of the ade1-14 UGA codon and suppression of the red
pigmentation associated with this allele. Treatments with
agents such as H2O2 or Cu(NO3)2 gave no change in colony
color compared with untreated controls, whereas red pig-
mentation was suppressed with paromomycin or CrO3 (Fig-
ure 4b), indicative of mistranslation [35]. Red pigmentation
was restored when pale colonies from Cr-supplemented
medium were sub-cultured onto non-supplemented medium
(not shown), indicating that Cr-dependent nonsense suppres-
sion did not stem from a prion switch or other heritable
change. Translational read-through due to Cr, but not paro-
momycin, was abolished under anaerobic conditions; this
indicates an oxidative basis for Cr-induced mistranslation
(Figure 4c).
The hypothesis that induction of mRNA mistranslation
causes Cr toxicity was tested first by assaying for synergistic
toxicity between Cr and paromomycin. These agents together
caused a far stronger growth-inhibitory effect than their
combined individual effects (Figure 5a), indicating that paro-
momycin (which provokes mistranslation via ribosome bind-
ing) and Cr target a common process. No synergy was found
between H2O2 and paromomycin (data not shown). Second,
we examined Cr resistance in 18S ribosomal RNA mutants
that carry out mRNA translation with differing degrees of
accuracy [36]. The L1583 mutant, which is characterized by
highly error-prone translation, was markedly sensitized to Cr
in comparison to the wild type (L1494); in contrast, increased
translational accuracy (strain L1597) caused increased Cr
resistance (Figure 5b). These results substantiated the
proposal that induction of mRNA mistranslation is the main
cause of chromium's toxic effect on yeast cells.
Chromium causes errors in mRNA translation Figure 4
Chromium causes errors in mRNA translation. (a) Cells transformed with the dual-luciferase plasmid [50] were exposed or not to 200 μg ml-1 
paromomycin ('Paro'), 0.6 mM Cu(NO3)2 or 0.1 mM CrO3, in YNB medium for 90 minutes. The activities of the firefly and renilla luciferases in derived 
protein extracts were determined luminometrically. The ratio of luminescence from the firefly versus renilla luciferase indicates the short-term level of 
translational read-through of the UAA stop codon that separates the two open reading frames. All values are means ± standard error of the mean from at 
least three independent determinations. RLU, relative light units. (b, c) Exponential-phase S. cerevisiae L1494 (ade1-14) cells (OD600 ~1.0, plus a 10-fold 
dilution) were spotted in 6 μl aliquots on to YEPD agar supplemented or not with 150 μg ml-1 paromomycin, 8 mM Cu(NO3)2, 0.15 mM CrO3 or 3.6 mM 
H2O2. Plates were incubated for 3 days at 30°C either aerobically (b) or anaerobically (c). In the latter case, plates were incubated aerobically at 4°C after 
the 3 days incubation to allow development of the red pigment before images were captured. The stressors were supplied at doses that produced similar 
degrees of mild inhibition of aerobic growth (versus controls) within each experiment on the different media.
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Discussion
The lack of understanding of the cellular and molecular
mechanisms that cause metal toxicity has contrasted starkly
with our appreciation of the detrimental consequences of
metal toxicology for human and animal health. Chromium
exposure, for example, is linked with carcinogenicity, liver
and kidney necrosis, and allergenicity [8]. In this study, the
complete collection of heterozygous deletion mutants of pro-
tein-encoding genes in the yeast S. cerevisiae was used to
determine the contribution of every gene, essential and non-
essential, to cellular resistance to chromium. This provides
the most comprehensive dataset yet available for elucidating
this metal's mode of action. Moreover, we have validated this
potential through the novel finding that the induction of mis-
translation is a major cause of Cr toxicity. This finding
stemmed from an observation that proteasomal functions
were over-represented in the annotations of genes that dis-
played haploinsufficiency in the presence of Cr. Given that
most of the proteasomal genes are essential, this result would
h a v e  b e e n  m i s s e d  i n  a  c o n v entional homozygous-mutant
screen, underscoring the importance of including essential
gene functions in this type of investigation.
Although metals are not necessarily expected to have essen-
tial proteins as their targets [5], we did identify candidate tox-
icity targets of that type, that is, haploinsufficient essential
genes. However, the concept of loss-of-function of an essen-
tial protein target (the focus of the drug-induced haploinsuf-
ficiency studies [14,15,21,24]) could be less relevant to mode-
of-action than toxic gain-of-function, for example, resulting
from Cr-induced formation of toxic protein aggregates. In
this scenario, candidate protein targets of Cr-mediated
toxicity would be among the haploproficient genes. The asso-
ciation between protein aggregation and Cr toxicity remains
to be resolved in full. However, we demonstrated that mRNA
mistranslation is a primary cause of Cr toxicity, and propose
that this toxicity is mediated by aggregation of the mistrans-
lated polypeptides.
It is known that protein (but not DNA) oxidation is required
for the process of Cr toxicity [32]. Chromium promotes the
generation of superoxide radicals in cells and there are over-
laps in the phenotypic effects of Cr and superoxide [32,37,38].
The superoxide-generating provitamin menadione is the only
classical pro-oxidant for which haploinsufficiency data are
already available [21]. The two genes giving the strongest
haploinsufficiency  in that report, GIM1  and  RPN10, have
functions related to the same principal GO categories identi-
fied here for Cr-induced haploinsufficiency: actin and protea-
some. Therefore, the present data support the superoxide-
related mode of toxicity suggested elsewhere for Cr [32].
These conclusions may be particularly relevant to toxicity in
humans as 80% of non-essential gene functions that influ-
ence yeast resistance to the superoxide-generating toxicant,
paraquat, have highly conserved human homologues [39].
Oxidative stress in yeast is associated with a Gcn2p-depend-
ent repression of translational initiation [40] and similar
responses occur in mammalian cells [41]. Combined with
translational inhibition additionally at a post-initiation step,
this results in a slowdown of protein synthesis that is thought
to preclude the potentially deleterious effects of continued
mRNA translation under the error-prone conditions of
oxidative stress [40]. This strategy of decreased mRNA
translation during oxidative stress appears to work in the case
of H2O2, as our data provided no evidence for H2O2-induced
mRNA mistranslation causes chromium toxicity Figure 5
mRNA mistranslation causes chromium toxicity. Exponential phase cells were sub-cultured in 300 μl volumes of YEPD in 48-well plates, and growth 
(OD600) was subsequently monitored at 30°C with continuous shaking in a plate reader. (a) Growth of S. cerevisiae BY4743 in unsupplemented medium 
(control; open circles), or in medium supplemented with 0.1 mM Cr (filled circles), or 100 μg ml-1 of the ribosome-targeting drug paromomycin (open 
squares), or 0.1 mM Cr + 100 μg ml-1 paromomycin (filled squares). (b) Growth of S. cerevisiae L1494 (wild type; circles), L1583 (error-prone translation; 
squares) and L1597 (high translational fidelity; triangles) strains in the absence (open symbols) or presence (filled symbols) of 0.1 mM CrO3. Typical results 
from one of three independent experiments are shown.
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mistranslation. In contrast, the key role for oxygen-depend-
ent mRNA mistranslation in Cr toxicity, revealed here, indi-
cated that translational shutdown is ineffective for Cr. This is
despite the fact that assays of translation initiation (C Mas-
carenhas and CM Grant, personal communication) and
[35S]methionine incorporation (S Holland and SV Avery,
unpublished data) have indicated that Cr provokes a decrease
in protein synthesis that is at least as marked as that provoked
by H2O2. Therefore, the ability to respond by decreasing the
rate of protein synthesis is not the only factor determining
resistance of cells to stressor-induced mistranslation. The
specific targeting of the translation process by Cr, indicated
by our work, provides a useful new tool for elucidating the
molecular mechanisms by which translational fidelity in cells
can fail.
Conclusion
This study has validated the use of the heterozygous yeast
mutant collection for mode-of-action discovery beyond ther-
apeutic compounds, with a natural agent not necessarily
expected to have essential proteins as its targets. This was
also the first study of this nature to exploit the stringency of
continuous culture in performing the necessary competitions
in a manner that is both highly reproducible and highly sen-
sitive. It is also unique in revealing haploproficient, as well as
haploinsufficient, phenotypes with a toxic agent. The screen-
ing data presented here provide the research community with
an authoritative resource for elucidating the molecular basis
of Cr toxicity. Moreover, the data led us to the discovery that
Cr induces the mistranslation of mRNA (and increased pro-
tein aggregation) and that this is a primary cause of Cr toxic-
ity. Development of new therapies for metal toxicity relies, at
least in part, on such advances and these aims should now be
closer at hand.
Materials and methods
Strains, oligonucleotides and plasmids
The heterozygous deletion strains, in the diploid BY4743
background (MATa/MATαhis3Δ 1/his3Δ 1 leu2Δ 0/leu2Δ 0
met15Δ  0/MET15 LYS2/lys2Δ  0 ura3Δ  0/ura3Δ  0) were
obtained from the Saccharomyces deletion consortium [42].
The strains were pooled as described elsewhere [22]. BY4743
was used for aggregate extraction, protein labeling and the
luciferase assay. The ribosomal mutant strains (L1494, L1597
and L1583) were kindly provided by Dr Susan Liebman (Uni-
versity of Illinois at Chicago).
Growth conditions
Competition experiments in chemostat culture were carried
out according to Colson et al. [43] using a small-scale multi-
ple fermenter system (Fedbatch-pro, Das Gip Technology,
Julic, Germany). Inoculation with the heterozygote pool and
culture in carbon-limited medium were as described by Del-
neri et al. [22], but with the inclusion of CrO3 (0.1 mM) or no
stressor. In brief, an aliquot (1 × 107 cells) of the pool of heter-
ozygous strains was inoculated into 120 ml of carbon-limiting
medium [44]. These were grown in batch for 24 h at 30°C
with shaking at 170 rev min-1, before continuous culture was
initiated at a dilution rate of 0.1 h-1 and a constant pH of 4.5.
Each competition experiment was conducted in two biologi-
cal replicates for at least 24 generations. Other experiments
were with strains cultured individually in YEPD or YNB
media [45,46]. Where specified, organisms were cultured in
300 μl volumes in 48-well plates (Greiner Bio-One, Stone-
house, Gloucestershire, UK) with shaking at 30°C in a BioTek
Powerwave microplate reader (BioTek, Vinooski, VT, USA).
Where specified, an anaerobic atmosphere (H2 + CO2) was
generated with an Oxoid Gas Generating Kit (Oxoid, Basing-
stoke, Hampshire, UK).
Genomic DNA extraction, tag amplification, and 
hybridization to tag-3 DNA microarrays
Samples (15 ml) of the organisms from competition experi-
ments were collected from the culture outflow as soon as the
continuous cultures reached steady state (time zero sample;
approximately 72 h after original inoculation) and also after
at least 24 generations of steady-state growth. Genomic DNA
was extracted from these using the DNA tissue kit (Qiagen,
Crawley, West Sussex, UK). The concentration of DNA in the
extract was determined using a Nanodrop device (Agilent
Technologies, South Queensferry, West Lothian, UK). The
universal primers used for amplification of the unique bar-
codes in the genomic DNA of the heterozygotes and the
hybridization protocol are those used by Winzeler et al. [10].
Amplifications and hybridizations for each genomic DNA
sample were carried out in duplicate, and each sample was
from one of two biological replicates of the relevant
competition.
Data analysis
Data from hybridizations were globally normalized by
median centering the intensity values from tags correspond-
ing to each heterozygous deletant (two tags per mutant). Log.-
ratios for each strain were then calculated between the initial
and final chemostat time points [22]. This served to eliminate
tag-specific biases and further normalized the data. The log.-
r a t i o s  w e r e  e x p r e s s e d  a s  c h a n g e  ( i n  r e l a t i v e  s t r a i n  a b u n -
dance) per number of cell generations; the latter correction
accounted for differences in the generations elapsed between
control and Cr-treated cultures (31 and 24 generations
respectively). For each strain, the differences in the mean
log.-ratios between the control incubations and incubations
with Cr indicated the size of the growth effect of Cr. These
growth effects were assessed for significance using the p value
obtained from an independent-samples t-test. To account for
multiple testing, false discovery rates (q-values) were esti-
mated [47], using the Qvalue v1.0 library implemented in the
statistical package R, version 2.4.1. Differences yielding a q-
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the corresponding open reading frames selected for further
analysis with GoMiner.
Intensity values from tags that do not correspond to deletion
mutants were taken as being representative of the back-
ground intensity. This was used as a baseline, enabling deter-
mination of the presence or absence of individual deletion
strains in the experiments. Several strains giving a median
signal that was not significantly different to this background
were strains that characteristically yield poor hybridization
signals [48] (termed 'PH'; Additional data file 1). Data for
these were removed from subsequent analyses. Some other
strains were lost (out-competed) during competitive culture.
Such strains that were not detected in the Cr condition but
were in the control condition (termed 'absent'; Additional
data file 1) were considered haploinsufficient. Strains that
were not detected in the control condition but were in the Cr
condition (termed 'present') were considered haploproficient.
These strains were included with the relevant haploinsuffi-
cient or haploproficient datasets, although the absence of a
hybridization signal under either the stressed or the control
condition precluded assignment of a q-value.
Protein extraction and metabolic labeling
Protein extraction (total, and the aggregated fraction) was as
described in Rand and Grant [49], with the modification of an
additional final wash in lysis buffer (minus Igepal), prior to
protein quantification with the Bradford assay (Bio-Rad Lab-
oratories, Hemel Hempstead, Hertfordshire, UK). The tech-
nique for isolation of aggregates involves solubilization and
separation of membrane proteins, so reducing the back-
ground of insoluble proteins in aggregate fractions. The term
'aggregated protein', as used in this paper, refers to those frac-
tions that include residual insoluble protein, separated from
total protein [49]. For radio-labeling, exponential-phase cells
(OD600 ~0.5) in 25 ml YNB medium were incubated with 1 μl
(10 μCi) [35S]methionine (MP Biomedicals, Cambridge, Cam-
bridgeshire, UK) ± CrO3 for 1 h at 30°C with shaking. Cells
were washed twice in chase medium (YNB plus 1 mg ml-1
unlabeled methionine) and protein was extracted and quanti-
fied, as above, either immediately or after 1 h incubation in
chase medium + CrO3. Incorporated isotope was quantified in
5 ml scintillation fluid (Emulsifier Safe, Perkin Elmer, Bea-
consfield, Buckinghamshire, UK) using a Packard Tri-Carb
2100TR liquid scintillation analyzer. Incorporation of
[35S]methionine was expressed as counts-per-minute (cpm)
per μg protein.
Dual luciferase assay
Cultures (5 ml) of cells transformed with the dual-luciferase
plasmid [50] (a kind gift from Dr David Bedwell, University of
Alabama), were grown to OD600  ~0.5 and treated with
Cu(NO3)2, CrO3 or paromomycin as specified. At intervals, 5
ml of cells were pelleted by centrifugation and resuspended in
60 μl of Passive Lysis Buffer (Promega, Southampton, Hamp-
shire, UK) before vortexing with 40 μl glass beads (0.5 mm
diameter, Biospec Products, Bartlesville, OK, USA)) for 10 ×
30 s, with a 30 s incubation on ice between each disruption.
The subsequent assay was with the Dual Luciferase Assay sys-
tem (Promega). Extracts were centrifuged at 15,000 g, 30 s
and 5 μl of supernatant added to 20 μl Luciferase Assay Rea-
gent II. Samples were read in a Berthold Lumat LB9507 lumi-
nometer for 10 s, 20 μl of Stop and Glo reagent was added and
the luminescence was again read for 10 s. Background meas-
urements obtained for cells that lacked the plasmid were sub-
tracted from test measurements. The derived ratio of
luminescence attributable to the firefly versus Renilla luci-
ferases indicated the level of UAA mis-translation.
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Additional data files
The following additional data are available with the online
version of this paper. Additional data file 1 is an Excel work-
book that gives the growth data for each heterozygote strain
under Cr stress. Additional data file 2 is an Excel workbook
that lists the over-represented GO terms among genes that
gave significant haploinsufficiency or haploproficiency. Addi-
tional data file 3 is a figure showing confirmation of chro-
mium sensitivity in individual heterozygous proteasome
mutants. Additional data files 4 and 5 are Excel workbooks
that give the raw Affymetrix data and log.-ratios, respectively,
for each strain under the control and Cr conditions.
Additional data file 1 Growth data for each heterozygote strain under Cr stress Growth data for each heterozygote strain under Cr stress. Click here for file Additional data file 2 Over-represented GO terms among genes that gave significant hap- loinsufficiency or haploproficiency Over-represented GO terms among genes that gave significant hap- loinsufficiency or haploproficiency. Click here for file Additional data file 3 Confirmation of chromium sensitivity in individual heterozygous  proteasome mutants Exponential-phase cells were sub-cultured, in 300 μl volumes of  YNB in 48-well plates, and growth (OD600) was subsequently mon- itored at 30°C with continuous shaking in a plate reader. Doubling  times were determined during the period of exponential growth in  the absence or presence of 0.1 mM CrO3, and the percent increase  in doubling time attributable to Cr (a measure of Cr sensitivity) was  calculated for each strain. The values are the means of three inde- pendent experiments ± standard error of the mean. Click here for file Additional data file 4 Affymetrix data for each heterozygote strain under the control and  Cr conditions Affymetrix data for each heterozygote strain under the control and  Cr conditions Click here for file Additional data file 5 Log.-ratio data for each heterozygote strain under the control and  Cr conditions Log.-ratio data for each heterozygote strain under the control and  Cr conditions Click here for file
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